BioLargo, Inc. Discusses Its PFAS Treatment Solution and Odor Control Technology with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - October 25, 2022) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. CEO of BioLargo, Dennis Calvert, joined Stock Day host Everett Jolly.
Jolly began the interview by asking about BioLargo's PFAS treatment technology. Calvert explained the origins of PFAS contamination and how it threatens water around the world. "These forever chemicals can lead to adverse health effects, birth defects, cancer, and all sorts of incredibly negative illnesses, with litigations happening all over the world," explained Calvert.
Calvert then discussed the challenges with current PFAS treatment solutions, which typically generate significant waste, creating an environmental hazard. In contrast, BioLargo's own treatment solution the Aqueous Electrostatic Concentrator (AEC) generates very little solid waste, making it both eco-friendly and logistically sound for customers.
"What is your roll out plan?", asked Jolly. Calvert explained that the company has several channel partners already on board to represent the AEC, and that several additional sales rep organizations have indicated they would also carry the AEC after discussions at recent trade shows. "We have shored up outsourced manufacturing with PRM [(Product Recovery Management)], which gives us the ability to be able to deliver machines and equipment to scale rapidly to combine with our own."
The conversation then turned to BioLargo's pet odor technology. "We have negotiated an arrangement with our partner where we have a cost plus arrangement," said Calvert. "We also [would] participate in the equity of the brand upon exit, equal to 20%," he continued. "That product is now doing over $100,000 per day in sales, which was a significant revenue contribution to our record performance last quarter," he shared. "They are ramping up, and are expecting to enter Walmart stores in November," said Calvert, adding that the company expects these sales to reflect in the fourth quarter and anticipates more major retailers coming onboard.
To close the interview, Calvert elaborated on BioLargo's significant potential as they continue to find adoption for their growing technology solutions. He also encouraged listeners to keep up-to-date on their current and upcoming projects by following the company's blog at https://biolargo.blogspot.com/.
To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8180691-biolargo-inc-discusses-its-pfas-treatment-solution-and-odor-control-technology-with-the-stock-d
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our approach is to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. We have developed a number of key channel partnerships to support the reach of our products and services and maximize their commercial potential. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 90 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.
Dennis P. Calvert
President and CEO, BioLargo, Inc.
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue and plans for future operations, and may be identified by words such as "we believe". These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company's business, results of operations, financial condition, and stock price; the effect of global and regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.
Stock Day Media
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/141860